Alithea Biotechnology GmbH
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Diagnostics
- Other products or services
- Digital health
- Other R&D services
Alithea empowers biopharma with the world’s most advanced HLA-peptide data platform to accelerate neoantigen discovery, validation, and safety profiling. Our end-to-end solution transforms patient samples into actionable insights using proprietary mass spectrometry, AI, and Big Data. By bridging cutting-edge science with scalable technology, we enable the development of highly personalized and effective cancer therapies—faster and safer. Alithea makes precision oncology a reality.



